This invention relates to hydroxamic acid derivatives having a urea linkage, that are inhibitors of histone deacetylase (HDAC), and are useful in the prevention and/or treatment of cellular proliferative diseases, for example cancer, autoimmune, allergic and inflammatory diseases, diseases of the central nervous system (CNS) such as neurodegenerative diseases, and in the prevention and/or treatment of restenosis.

 
Web www.patentalert.com

< Apparatus and methods for vacuum- and mechanically-assisted fixation of medical electrical leads

< Automated manipulation of imaging device field of view based on tracked medical device position

> Device for carrying out rotablation

> Peptides for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons
~ 00614